Anavex Life Sciences Corp.
AVXL
Revenue
0.00
0.000.00%
-Assets
124.04M
▼-11.52M▼-8.50%
3 Months ChangeLiabilities
13.13M
▼-2.18M▼-14.22%
3 Months ChangeFree Cash Flow
-2.66M
▼-2.66M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-06
Form 10-Q
ID: 0001731122-24-001207
2024-07-30
Form 8-K
ID: 0001731122-24-001160
2024-06-21
Form 8-K
ID: 0001731122-24-001003
2024-05-09
Form 10-Q
ID: 0001731122-24-000760
2024-05-09
Form 8-K
ID: 0001731122-24-000758
2024-02-07
Form 10-Q
ID: 0001731122-24-000206
2023-08-08
Form 10-Q
ID: 0001731122-23-001412
2023-05-24
Form 8-K
ID: 0001731122-23-001007
2023-05-09
Form 10-Q
ID: 0001731122-23-000845
2023-04-14
Form 8-K
ID: 0001731122-23-000651